Mycophenolate has been added to the list of approved DMARD drugs in the ABUHB Near Patient LES. Ina addition there has been clarification regarding patients who may be on 2 or more DMARD Drugs simultaneously.

"In the event that a patient is prescribed more than one Near Patient Testing drug practices must seek authorisation from the Deputy Medical Director in advance of claiming multiple reimbursement. Where authorisation has been granted practices can then claimfor each drug individually; they must clearly demonstrate the additional workload requiredfor each drug e.g. completely different tests at different frequencies. This must be clearly recorded within the patient record. The Primary Care Team will notify NWSSP as to each approval so that payments can be processed accordingly."